Controversial research aims to develop more potent H7N9

10/24/2013 | New York Post

Scientists Ron Fouchier and Ab Osterhaus are manipulating the genome of the H7N9 avian influenza virus in an effort to create a strain that is easily transmissible among humans. They say developing such a strain would be a major advancement in learning how to prevent and treat the already deadly influenza virus, which has killed 45 of the 136 people who have been infected. However, opponents think the work is risky. Steven Salzberg, a professor at the Johns Hopkins University School of Medicine, said, "The notion of 'gain of function' research on pathogens is very, very dangerous."

View Full Article in:

New York Post

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC